 NOVATO, Calif., Sept. 01, 2021 GLOBE NEWSWIRE -- Ultragenyx Pharmaceutical Inc. NASDAQ: RARE, a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the companys Chief Executive Officer and President will participate in a panel titled Finding a Needle in a Haystack - Drug Development Strategies for Rare Disease on Thursday, September 9, 2021 at Citis 16th Annual BioPharma Healthcare Conference at 4:10 PM ET. 